MetLife Investment Advisors »

Immix Biopharma shares owned by MetLife Investment Advisors

Quarter-by-quarter ownership of Immix Biopharma (IMMX) shares owned by MetLife Investment Advisors from 13F filings

Historical chart of MetLife Investment Advisors investment in Immix Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Immix Biopharma held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immix Biopharma by MetLife Investment Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $257k 25k 10.31

More positions owned by MetLife Investment Advisors

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Alphabet Inc Class A Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
Alphabet Inc Class C Cap Stk Cl C (GOOG)
Micron Technology (MU)
Meta Platforms Inc Class A Cl A (META)
Tesla Motors (TSLA)
Eli Lilly & Co. (LLY)
Advanced Micro Devices (AMD)
Berkshire Hathaway Inc Class B Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)
Vanguard Short-term Bond Index Fun Short Trm Bond (BSV)

View all positions for MetLife Investment Advisors

Top funds holding Immix Biopharma

Jupiter Topco
Henderson Group
Saturn V Capital Management
Eventide Asset Management
BlackRock
Deep Track Capital
Vanguard Capital Management
Opaleye Management
Millennium Management
UBS Group
Marshall Wace
Wellington Management Company
Dr. Jeffrey R. Jay, M.D.
Geode Capital Management
Velan Capital Investment Management

View all funds holding Immix Biopharma